Anais Nicol
Overview
Explore the profile of Anais Nicol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mourtada J, Lony C, Nicol A, De Azevedo J, Bour C, Macabre C, et al.
Front Immunol
. 2023 Nov;
14:1264093.
PMID: 38022675
Background: Deconvoluting the heterogenous prognosis of Human Papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OSCC) is crucial for enhancing patient care, given its rapidly increasing incidence in western countries and the...
2.
Mirjolet C, Nicol A, Limagne E, Mura C, Richard C, Morgand V, et al.
Sci Rep
. 2021 Jun;
11(1):13444.
PMID: 34188135
Radiotherapy delivered using photons induces an immune response that leads to modulation of the tumor microenvironment. Clinical studies are ongoing to evaluate immune checkpoint inhibitors in association with photon radiotherapy....
3.
Waissi W, Nicol A, Jung M, Rousseau M, Jarnet D, Noel G, et al.
Cancers (Basel)
. 2021 Feb;
13(3).
PMID: 33573176
Over the past few years, studies have focused on the development of targeted radiosensitizers such as poly(ADP-ribose) polymerase inhibitors. We performed an in vivo study and a whole-transcriptome analysis to...
4.
Waissi W, Paix A, Nicol A, Noel G, Burckel H
Crit Rev Oncol Hematol
. 2020 Jul;
153:103060.
PMID: 32707435
Background: Current research that combines radiation with targeted therapy may dramatically improve prognosis of pancreatic ductal adenocarcinoma (PDAC). We investigated preclinical outcomes of DNA repair inhibitor targeted therapy associated with...
5.
Chevalier F, Hamdi D, Lepleux C, Temelie M, Nicol A, Austry J, et al.
Technol Cancer Res Treat
. 2019 Sep;
18:1533033819871309.
PMID: 31495269
Chondrosarcomas are malignant tumors of the cartilage that are chemoresistant and radioresistant to X-rays. This restricts the treatment options essential to surgery. In this study, we investigated the sensitivity of...